| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/23/2012 | US20120046240 Method of Producing Hydroxyalkyl Starch Derivatives |
| 02/23/2012 | US20120045517 TREATMENT OF CELIAC DISEASE WITH IgA |
| 02/23/2012 | US20120045516 Composition for photodynamic therapy comprising a macromolecular capsule |
| 02/23/2012 | US20120045515 Hollow silica particle with a polymer thereon |
| 02/23/2012 | US20120045514 Anti-cancer microparticle |
| 02/23/2012 | US20120045513 Polymer-based, sustained release drug delivery system |
| 02/23/2012 | US20120045512 Methods and substrates for differentiation of neural stem cells |
| 02/23/2012 | US20120045511 Thermosensitive hepatitis b vaccine |
| 02/23/2012 | US20120045510 Tablet sleeve for improved performance |
| 02/23/2012 | US20120045509 Modified release compositions for dpp-iv inhibitors |
| 02/23/2012 | US20120045508 Method and composition for administering an nmda receptor antagonist to a subject |
| 02/23/2012 | US20120045507 Stable soft capsule dosage form for acetylsalicylic acid |
| 02/23/2012 | US20120045506 Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising neutral vinyl polymers and excipients |
| 02/23/2012 | US20120045505 Fixed dose drug combination formulations |
| 02/23/2012 | US20120045504 oral drug devices and drug formulations |
| 02/23/2012 | US20120045503 Compositions And Methods For Wound Healing |
| 02/23/2012 | US20120045502 Antagonists of muc1 |
| 02/23/2012 | US20120045501 Connexin enhances chemotherapy-included apoptosis in human cancer cells inhibiting tumor cell proliferation |
| 02/23/2012 | US20120045500 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 02/23/2012 | US20120045499 Pearlescent pigment surface treatment for confectionery |
| 02/23/2012 | US20120045494 Gum Base |
| 02/23/2012 | US20120045493 Solid Cosmetic Composition with Structurant and Electrolyte Solution |
| 02/23/2012 | US20120045489 Nano-Emulsion Injection of Vinca Alkaloids and the Preparation Method Thereof |
| 02/23/2012 | US20120045488 Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby |
| 02/23/2012 | US20120045487 Multiphasic microfibers for spatially guided cell growth |
| 02/23/2012 | US20120045486 Delivery systems |
| 02/23/2012 | US20120045485 Sustained release dosage form |
| 02/23/2012 | US20120045484 Calcium phosphate/sulfate-based bone implant composition |
| 02/23/2012 | US20120045483 Mannitol and/or Proline for Prevention and Treatment of Ageing Related Symptoms |
| 02/23/2012 | US20120045482 Policosanol nanoparticles |
| 02/23/2012 | US20120045481 Preventive and/or ameliorative agent for diseases, stamina enhancement agent, anti-fatigue agent, and pharmaceutical and food and drink using them |
| 02/23/2012 | US20120045480 composition comprising silver nanoparticles and extracts of polygonum multiflorum thunb and the use thereof |
| 02/23/2012 | US20120045479 Dry Powder Formulations, Vaccines and Methods |
| 02/23/2012 | US20120045463 Methods and compositions comprising supramolecular constructs |
| 02/23/2012 | US20120045456 Stabilized anti-respiratory syncytial virus (rsv) antibody formulations |
| 02/23/2012 | US20120045394 Human and mouse targeting peptides identified by phage display |
| 02/23/2012 | CA2844292A1 Devices and methods for intravaginal delivery of drugs and other substances |
| 02/23/2012 | CA2809022A1 Phospholipid depot |
| 02/23/2012 | CA2808907A1 Therapeutic peptide-polymer conjugates, particles, compositions, and related methods |
| 02/23/2012 | CA2808901A1 Conjugates, particles, compositions, and related methods |
| 02/23/2012 | CA2808710A1 Functional food compositions and methods |
| 02/23/2012 | CA2808628A1 Ophthalmic formulations of squalamine |
| 02/23/2012 | CA2808622A1 Method of stabilizing and sterilizing peptides or proteins |
| 02/23/2012 | CA2808574A1 Particle size breakup apparatus |
| 02/23/2012 | CA2808546A1 Gastric resistant pharmaceutical or nutraceutical formulation comprising one or more salts of alginic acid |
| 02/23/2012 | CA2808276A1 Intravaginal devices, methods of making, and uses thereof |
| 02/23/2012 | CA2808207A1 A novel method for creating, suspending and stabilizing electronically modified reaction intermedeates |
| 02/23/2012 | CA2808019A1 Particulate substances comprising ceramic particles for delivery of biomolecules |
| 02/23/2012 | CA2807753A1 Concentrate for medical solutions, production thereof and use thereof in dialysis |
| 02/23/2012 | CA2807419A1 Diketones and hydroxyketones as catenin signaling pathway activators |
| 02/23/2012 | CA2807319A1 Tablet sleeve for improved performance |
| 02/23/2012 | CA2805624A1 Compositions and methods for improved organ transplant preservation and acceptance |
| 02/23/2012 | CA2804333A1 Nalbuphine-based formulations and uses thereof |
| 02/22/2012 | EP2420580A1 Probiotic composition for oral health |
| 02/22/2012 | EP2420517A1 Polysaccharide derivative and hydrogel thereof |
| 02/22/2012 | EP2420247A1 Adenovirus formulations |
| 02/22/2012 | EP2420241A1 Transdermal delivery of beneficial substances effected by a hostile biophysical environment |
| 02/22/2012 | EP2420227A1 Targeted sustained-release microsphere of vascular occlusive agent containing sodium alginate and sorafenib, production method and use thereof |
| 02/22/2012 | EP2420226A1 Pharmaceutical compositions of rifaximin |
| 02/22/2012 | EP2420225A1 Methods and compositions for deterring abuse of opioid containing dosage forms |
| 02/22/2012 | EP2420224A1 Method for producing a stable 3-(2,2,2-trimethylhydrazinium)propionate dihydrate solid pharmaceutical composition |
| 02/22/2012 | EP2420223A1 Aqueous pharmaceutical compositions containing borate-polyol complexes |
| 02/22/2012 | EP2419732A1 Prion-free nanoparticle compositions and methods |
| 02/22/2012 | EP2419176A1 Pharmaceutical composition comprising glycerol, white soft paraffin and liquid paraffin for the treatment of uremic xerosis and/or pruritus |
| 02/22/2012 | EP2419139A2 Polymeric drug delivery systems and processes for producing such systems |
| 02/22/2012 | EP2419138A1 Gel compositions for administration of pharmaceutically active compounds |
| 02/22/2012 | EP2419114A1 Bacterial compositions for prophylaxis and treatment of degenerative disease |
| 02/22/2012 | EP2419108A1 Method for on-demand contraception |
| 02/22/2012 | EP2419091A2 Nanochanneled device and related methods |
| 02/22/2012 | EP2419090A1 Bioavailable capsule compositions of amorphous alpha-(n-sulfonamido)acetamide compound |
| 02/22/2012 | EP2419089A1 Formulation for stabilizing proteins, which is free of mammalian excipients |
| 02/22/2012 | EP2419088A1 Method for preparing pharmaceutical compositions comprising fine particles of active substance |
| 02/22/2012 | EP2419087A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it |
| 02/22/2012 | EP2419086A2 Bioavailable compositions of amorphous alpha-(n-sulfonamido)acetamide compound |
| 02/22/2012 | EP2419085A2 Improved oral drug devices and drug formulations |
| 02/22/2012 | EP2419084A2 A medicinal cream made using clotrimazole and chitosan and a process to make the same |
| 02/22/2012 | EP2419083A2 A medicinal cream made using silver sulphadiazine and chitosan and a process to make it |
| 02/22/2012 | EP2419082A2 Topical pharmaceutical composition containing a water-sensitive active principle |
| 02/22/2012 | EP2419081A1 Aqueous ophthalmic compositions containing anionic therapeutic agents |
| 02/22/2012 | EP2418969A1 Anti-reflux infant nutrition |
| 02/22/2012 | EP2418968A2 Method of producing microbeads |
| 02/22/2012 | EP2418945A1 Mineral salt-sulfonic acid compositions and methods of use |
| 02/22/2012 | EP2418941A1 Enzyme delivery systems and methods of preparations and use |
| 02/22/2012 | EP2091520B1 Oral dosage form comprising tri-substituted glycerol compounds |
| 02/22/2012 | EP2034972B1 Enteric coated particles containing an active ingredient |
| 02/22/2012 | EP1858957B1 Polyoxyalkylene-alkyl functional siloxane resins and aqueous compositions thereof |
| 02/22/2012 | EP1786405B1 Use and compounds for perceiving or controlling alcool intake |
| 02/22/2012 | EP1784163B1 Nano-emulsion, the use thereof, and preparation method thereof |
| 02/22/2012 | EP1652517B1 Hyaluronic acid nanoparticles |
| 02/22/2012 | EP1648496B1 Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment |
| 02/22/2012 | EP1592401B1 Process for modifying drug crystal formation of mycophenolate sodium salt |
| 02/22/2012 | EP1575566B1 Multilayer dosage forms containing naproxen and triptans |
| 02/22/2012 | EP1567007B1 Compositions and methods for cancer diagnosis and therapy |
| 02/22/2012 | EP1558226B1 Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics |
| 02/22/2012 | EP1524975B9 Improved transdermal delivery system for the administration of rotigotine |
| 02/22/2012 | EP1104287B1 Method for the preparation of oxide microcapsules loaded with functional molecules and the products obtained thereof |
| 02/22/2012 | CN202146449U 装有洛匹那韦片和利托那韦片剂胶囊 Equipped with lopinavir and ritonavir tablet tablets Capsules |
| 02/22/2012 | CN202146448U 具有降血糖、血脂功效的茶色素胶囊 Tea pigment capsule has a hypoglycemic, lipid efficacy |
| 02/22/2012 | CN1947749B 一种由头花蓼和茯苓制成的药物组合物 One kind of flower Polygonum and the head of a pharmaceutical composition made Tuckahoe |
| 02/22/2012 | CN1813833B 一种由当归和川芎组成的药物组合物及其制法 One kind of Angelica and Chuanxiong by pharmaceutical composition consisting Jiqizhifa |